Prakash: Most stem cell clinical data supports joint and knee treatments
Prashanth Prakash · Ep #21 | WTF is Longevity? | Nikhil ft. Nithin Kamath, Bryan Johnson, Prashanth, Jitendra & Seema · Nikhil Kamath · Feb 2, 2025 · at 3:07:40
Prashanth Prakash, partner at Accel India, discusses the current state of clinical evidence and applications in regenerative medicine with Nikhil Kamath.
0:00 / 0:09exact quote · 9.5s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“I think the most data is on stem cell therapy for joints and knees. I think there is some reasonable amount of data for that.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Prashanth Prakash
Prakash: Indians need lower BMI cutoffs than Westerners
“BMI levels in India need to be lower because our fat thresholds are lower, right? Unless in Indian doctors and in have had this now, and where did this data get kind of research in Singapore, right? Because they are putting money into doing this research to se…”
Prashanth Prakash: 2% to 3% of startups drive 80% of VC returns
“It's usually two to three percent of your portfolio that will return 80%, that will give you 80% of your returns. I mean, it's that skewed.”
Prashanth Prakash: Global LPs expect a 20% net dollar IRR in India
“Compounded, they would like to see that some, something in the neighborhood of 20% net dollar IRR. Net IRR. After the fees.”
Prashanth Prakash: Only two Indian startups raised $50M+ external rounds in 2023
“From new externally led rounds, there's been two this year. So it's a tough market.”
Prashanth Prakash: Indian exports growing to $1.5T is the next major opportunity
“I think the next huge opportunity For Indian entrepreneurs used to take the export market from 700 or eight hundred billion that it is today to one and a half trillion, right?”
Prashanth Prakash: Building product before deep problem insight causes startup failure
“If somebody is looking to build product ahead of insight and a deeper appreciation for what really the problem is, I think I've seen that as a recipe for disaster in most companies. What they will have is a hundred member tech team. ... Very average product be…”